NCT02310477 2026-03-13
REBECCA
Centre Oscar Lambret
Completed
Clinical Trials
9 trialsNCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT04810182 2024-02-08
Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
Istituto Oncologico Veneto IRCCS
Completed
NCT05993702 2023-08-15
TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
China Medical University, China
Unknown
NCT05942768 2023-07-12
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Hunan Cancer Hospital
Completed
NCT05811481 2023-04-13
ROSE
First Affiliated Hospital, Sun Yat-Sen University
Unknown
NCT05557656 2022-12-29
A Real World Study of Regogfinib in HCC
Zhongda Hospital
Unknown
NCT04771715 2021-02-25
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
Peking Union Medical College Hospital
Unknown
NCT04431791 2020-06-16
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer
Peking University
Unknown